Search by Drug Name or NDC

    NDC 00338-0126-12 MYXREDLIN 1 [iU]/mL Details

    MYXREDLIN 1 [iU]/mL

    MYXREDLIN is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is INSULIN HUMAN.

    Product Information

    NDC 00338-0126
    Product ID 0338-0126_a81a584d-6d29-4dc6-b74a-8d4831c1bcb7
    Associated GPIs 27104010122020
    GCN Sequence Number 079935
    GCN Sequence Number Description insulin regular in 0.9 % NaCl PLAST. BAG 100/100 ML INTRAVEN
    HIC3 C4G
    HIC3 Description INSULINS
    GCN 46567
    HICL Sequence Number 012655
    HICL Sequence Number Description INSULIN REGULAR, HUMAN IN 0.9 % SODIUM CHLORIDE
    Brand/Generic Brand
    Proprietary Name MYXREDLIN
    Proprietary Name Suffix n/a
    Non-Proprietary Name insulin human
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 1
    Active Ingredient Units [iU]/mL
    Substance Name INSULIN HUMAN
    Labeler Name Baxter Healthcare Corporation
    Pharmaceutical Class Insulin [CS], Insulin [EPC]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA208157
    Listing Certified Through 2024-12-31

    Package

    NDC 00338-0126-12 (00338012612)

    NDC Package Code 0338-0126-12
    Billing NDC 00338012612
    Package 12 CONTAINER in 1 CARTON (0338-0126-12) / 100 mL in 1 CONTAINER
    Marketing Start Date 2019-07-12
    NDC Exclude Flag N
    Pricing Information N/A